Dabigatran versus warfarin in the treatment of acute venous thromboembolism

Schulman, Sam;Kearon, Clive;Kakkar, Ajay K;Mismetti, Patrick;Goldhaber, Samuel Z;et.al.
(2009) The New England journal of medicine —

Files

No attached file found for this publication.

Details

Authors
  • Schulman, Sam
    Author
  • Kearon, Clive
    Author
  • Kakkar, Ajay K
    Author
  • Mismetti, Patrick
    Author
  • Goldhaber, Samuel Z
    Author
Show more
Abstract
The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009). Dabigatran versus warfarin in the treatment of acute venous thromboembolism. The New England journal of medicine. https://doi.org/10.1056/NEJMoa0906598